REGENXBIO Announces Pricing of Public Offering of Common Stock and Pre-funded Warrants

Summary

REGENXBIO announced pricing of an underwritten public offering of approximately 10 million shares at $9.00 per share and 1.1 million pre-funded warrants at $8.9999 per warrant, raising approximately $99.6 million in gross proceeds.